# VITRAKVI

NDC: 71777-391
Generic name: LAROTRECTINIB
Labeler / Manufacturer: Loxo Oncology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20181126

FDA application: NDA210861

## Active ingredients

- LAROTRECTINIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71777-391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71777-391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9525f887-a055-4e33-8e92-898d42828cd1